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Napaporn Kuamsab, Chaturong Putaporntip, Urassaya Pattanawong and Somchai Jongwutiwes*Abstract
Background: Gametocyte carriage is essential for malaria transmission and endemicity of disease; thereby it is a
target for malaria control strategies. Malaria-infected individuals may harbour gametocytes below the microscopic
detection threshold that can be detected by reverse transcription polymerase chain reaction (RT-PCR) targeting
gametocyte-specific mRNA. To date, RT-PCR has mainly been applied to the diagnosis of Plasmodium falciparum
gametocytes but very limited for that of Plasmodium vivax.
Methods: A multiplex-nested RT-PCR targeting Pfs25 and Pvs25 mRNA specific to mature gametocytes of P.
falciparum and P. vivax, respectively, was developed. The assay was evaluated using blood samples collected in
rainy and dry seasons from febrile patients,in a malaria-endemic area in Thailand. Malaria diagnosis was performed
by Giemsa-stained blood smears and 18S rRNA PCR.
Results: The multiplex-nested RT-PCR detected Pfs25 mRNA in 75 of 86 (87.2%) P. falciparum-infected individuals
and Pvs25 mRNA in 82 of 90 (91.1%) P. vivax malaria patients diagnosed by 18S rRNA PCR. Gametocytes were
detected in 38 (eight P. falciparum and 30 P. vivax) of 157 microscopy positive samples, implying that a large
number of patients harbour sub-microscopic gametocytaemia. No seasonal differences in gametocyte carriage were
observed for both malaria species diagnosed by multiplex-nested RT-PCR. With single-nested RT-PCR targeting Pfs25
or Pvs25 mRNA as standard, the multiplex-nested RT-PCR offered sensitivities of 97.4% and 98.9% and specificities of
100% and 98.8% for diagnosing mature gametocytes of P. falciparum and P. vivax, respectively. The minimum
detection limit of the multiplex-nested PCR was 10 copies of templates.
Conclusions: The multiplex-nested RT-PCR developed herein is useful for simultaneous assessment of both P.
falciparum and P. vivax gametocyte carriage that is prevalent and generally sympatric in several malaria-endemic
areas outside Africa.
Keywords: Malaria diagnosis, Gametocyte, Reverse transcription polymerase chain reaction, Plasmodium falciparum,
Plasmodium vivax, Pfs25, Pvs25Background
Gametocytes, the precursors of male and female gametes,
of malaria parasites are formed in the human host through
the developmental switch from asexual replication in ery-
throcytes. Although gametocytes are not responsible for
clinical symptoms, they ensure the transmission of malaria
to another host. Upon taking a blood meal, gametocytes* Correspondence: jongwutiwes@gmail.com
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reproduction in any medium, provided the orare transferred to a mosquito’s midgut lumen where they
differentiate into male and female gametes. After complete
sexual reproduction and successive processes of sporogo-
nic development, mature sporozoites accumulate in the
vector’s salivary gland, ready to be inoculated into a new
host. Therefore, the presence of gametocytes in circulation
of infected individuals is imperative for malaria to remain
endemic in a given community. Malaria control strategies
aiming at interruption of the malaria transmission process
require knowledge on the status of gametocyte carriage in
each endemic area [1].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cytes in circulation of patients occurs at much lower dens-
ities than asexual stages and usually circulates at the level
close to or below microscopic detection threshold, making
it liable to be undiagnosed by microscopy [2,3]. Several
epidemiological surveys have shown that only a subset of
malaria-infected individuals possessed gametocytes upon
microscopic examination of the blood smears [3-7]. Im-
portantly, these gametocyte-negative blood samples re-
main infective to anopheline vectors akin to those that
have patent gametocytaemia [6-8]. On the other hand,
molecular detection of Plasmodium gametocytes has
revealed that a considerable number of malaria patients
whose blood samples were gametocyte-negative by mi-
croscopy actually had sub-microscopic gametocytaemia
[3-7]. Therefore, microscopy detection of gametocytes
could underestimate and thereby mislead evaluation of
malaria transmission potential in endemic areas.
Molecular diagnostics of malarial gametocytes are
based on amplification of mRNA transcripts that are ex-
clusively expressed during gametocyte stages. Some of
these transcripts are synthesized in co-ordination with
specific periods of gametocyte development while some
are sex-specific [9,10]. Therefore, specific mRNA tran-
scripts could serve as appropriate markers for diagnos-
ing stages of gametocytes. Of these, transcription of
Pfs25 begins when gametocytes of Plasmodium falcip-
arum become mature (stage V) and continues until the
formation of ookinetes [11]. Importantly, homologues of
Pfs25 have been identified in several other malaria, e.g.
Pvs25, Pbs25, Pgs25 and Pys25 in Plasmodium vivax,
Plasmodium berghei, Plasmodium gallinaceum and Plas-
modium yoelii, respectively [12]. To date, molecular epi-
demiological studies have been largely performed to
assess P. falciparum gametocyte carriage because it is
the most prevalent and most pernicious malaria species
that requires urgent effective control measures. On the
other hand, a few reports have demonstrated molecular
application for diagnosing P. vivax gametocytes [5,13]
despite the fact that it is the most widely distributed spe-
cies with relapsing potential and is responsible for an
important global public health burden [14].
Both P. falciparum and P. vivax are major malaria spe-
cies and sympatric in several endemic areas outside Af-
rica [15]. Therefore, epidemiological surveillance or
assessment of malaria transmission by estimation of
both P. falciparum and P. vivax gametocyte carriage in
each endemic area is essential for malaria control policy.
Because the expense of reagents and turnaround time in
multiplex PCR are less than single PCR, a multiplex-
nested RT-PCR assay targeting Pfs25 and Pvs25 is devel-
oped for rapid detection and differentiation of P. falcip-
arum and P. vivax gametocytes simultaneously.
Diagnostic performance of the method was evaluatedusing blood samples collected during both high and low
transmission seasons from malaria patients in an en-
demic area of Thailand.
Methods
Clinical sample collection and study area
Blood samples (~1 mL) were collected from 235 febrile
patients (136 males and 99 females; mean age 21.7 years,
range seven to 77 years) who attended a malaria clinic at
Umpang District in Tak Province (GPS N16° 1′ 000, E98°
51′ 4600), north-western Thailand bordering Myanmar,
during the rainy season (from June to August 2010) and
the dry season (from November 2010 to January 2011).
All except one patient had febrile onset one day prior to
blood sample collection. In total, 157 patients had mal-
aria in their circulation based on microscopic diagnosis
of Giemsa-stained blood smears. Malaria was not found
by microscopy in the remaining 78 febrile individuals.
Each blood sample was divided and preserved separately
in EDTA and RNAlaterTM (Ambion, USA). Exclusion
criteria were those having previous anti-malarial treat-
ment or presence of clinical signs and symptoms of se-
vere malaria [16]. Informed consent was obtained from
each patient or from a parent or guardian for those aged
less than 18 years. The ethical aspects of this study have
been approved by the Institutional Review Board of Fac-
ulty of Medicine, Chulalongkorn University.
Microscopy
Both thin and thick blood smears were prepared from
each patient and stained with Giemsa solution for
microscopic diagnosis of malaria species and stages.
Parasite density was assessed from a thick blood film for
≥200 leukocytes with a 100× objective. Estimation of
parasite density was performed by assuming a standard
count of 7,000 leucocytes/μL [17]. Each stained slide was
examined independently by two microscopists who were
blinded to each other results. The mean values of para-
site density were used for further analysis.
DNA and RNA extraction
DNA was extracted from 200 μL of EDTA-preserved
blood samples using QIAGEN kit following the instruc-
tion protocol except for elution with 30 μL TE buffer.
Blood samples (200 μL) preserved in RNAlaterTM were
used for RNA extraction using QIAamp RNA blood
mini kit (Qiagen, Germany) and eluted with 30 μL of
RNase-free water. cDNA was generated from two μL of
each RNA sample and amplified by using Takara RNA
PCR kit (AMV) version 3.0 (Takara, Japan) in a total vol-
ume of 10 μL. Two μL of RNA products of each sample
were used as template during subsequent PCR assay to
exclude possible genomic DNA contamination in cDNA
templates.
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Nested PCR targeting the small subunit ribosomal RNA
gene (18S rRNA PCR) of all four human malaria species
and. Plasmodium knowlesi was done following protocol
and amplification conditions as described previously
[18,19]. Results were obtained from 2% agarose gel elec-
trophoresis, stained with ethidium bromide solution and
visualized under UV transillumination.
Positive and negative controls
Positive controls for Pfs25 were genomic DNA and
cDNA of a clinical isolate that contained 315 mature P.
falciparum gametocytes/μL. For Pvs25, genomic DNA
and cDNA of a P. vivax clinical isolate harbouring 385
mature P. vivax gametocytes/μL were used as positive
controls. Verification of single species infection in these
control samples was done by using 18S rRNA PCR. Ster-
ile water was used as negative control.
Multiplex-nested RT-PCR targeting Pfs25 and Pvs25
Primers for primary PCR (primers FV25F0 and FV25R0)
were used to amplify both Pfs25 and Pvs25 and those for
secondary PCR were specific to each Plasmodium spe-
cies (Table 1). Secondary PCR was performed using pri-
mers F25F1 and F25R1 specific for Pfs25 and primers
V25F1 and V25R1 specific for Pvs25 in the same reac-
tion tubes. Optimization of PCR was performed by ad-
justment of thermal cycler profiles and concentration of
primers to obtain a final condition that provided good
intensities for both amplicons without non-specific
bands. The optimal DNA amplification was carried out
in a total volume of 20 μL containing 2 μL of cDNA
template, 2.5 mM each deoxynucleotide triphosphate, 2
μL of 10x PCR buffer, 1.6 μL of 25 mM MgCl2, 0.08 μL
of 30 μM of each primer for primary PCR and 0.4 units
of rTaq DNA polymerase (Takara, Seta, Japan). Thermal
cycler profile for primary PCR contains 94°C for 1 m for
one cycle; 94°C for 40 s, 55°C for 30 s and 72°C for 30 s
for 25 cycles; and 72°C for 5 m for one cycle. Secondary
PCR contained similar reaction mixtures except that
0.06 μL of 30 μM of each secondary PCR primer and 1Table 1 PCR primers used for amplification of Pfs25 and Pvs2
Gene target Primers Sequences (5′ ! 3′)
Primary PCR







* and # after GenBankTM accession numbers X07802 and GU256271 for Pfs25 and PμL of primary PCR product as template were used. A
total of 26 amplification cycles were used for secondary
PCR. The amplification products were analysed by 2%
agarose gel electrophoresis.
Detection of Pfs25 and Pvs25 by single-nested RT-PCR
The PCR primers and amplification conditions for
single-nested RT-PCR were essentially the same as those
for multiplex-nested RT-PCR except that secondary PCR
was performed in separate reaction tubes for each pair
of primers. The number of amplification cycles for pri-
mary PCR and secondary PCR were essentially the same
as single-nested PCR assays.
Detection limit and specificity
To estimate the detection limit of the developed meth-
ods, the entire Pfs25 using primers PFS25F0, 5′-
ATGAATAAACTTTACAGTTTG-300 (nucleotides 75–
95, positions after GenBankTM accession no. X07802)
and PFS25R0, 5′-TTACATTATAAAAAAGCATACTG-
3′ (nucleotides 706–728) was amplified by PCR. Ampli-
fication condition contained 94°C for 1 m; 35 cycles of
94°C for 40 s, 53°C for 30 s and 72°C for 30 s; and 72°C for
5 m. Likewise, the entire Pvs25 was amplified using pri-
mers PVS25F0, 5′-ATGAACTCCTACTACAGCCTC-3′
(nucleotides 1–21, positions after GenBankTM accession
no. GU256271) and PVS25R0, 5′-TTATATGACGTACG
AAGGGAC-3′ (nucleotides 640–660) with the same amp-
lification conditions. The PCR products of Pfs25 and
Pvs25 comprised 654 and 660 bp (henceforth Pfs25L and
Pvs25L), respectively, equivalent to 6.88× 10−7 and
6.94× 10−7 pg; thereby the copy number of each DNA
template could be calculated. After the PCR-amplified pro-
ducts were gel purified, the concentration of each template
was determined using the NanoDrop apparatus (Thermo
Fisher Scientific, Delaware, USA). The dilutions of 1× 106,
1 × 105, 1 × 104, 1 × 103, 1 × 102, 10, 1 and 0.1 copy/μL were
used as templates for determination of the detection limit
of each gene target. To test whether co-existence of P. fal-
ciparum and P. vivax could influence sensitivity of each
PCR assay, artificially mixed DNA templates from both5
Nucleotide positions Product size (bp)
AA 237–257* or 163–183# 264 for P. falciparum











Figure 1 Multiplex nested RT-PCR targeting Pfs25 and Pvs25.
Representative 2% agarose gel electrophoresis showing specific
amplifications generated from secondary PCR. Lane M, 50-bp ladder
marker; lanes 1–6, P. falciparum genomic DNA, P. vivax genomic
DNA, water as negative control, P. falciparum cDNA, P. vivax cDNA
and mixed P. falciparum and P. vivax cDNA, respectively. Molecular
size in base pairs is shown on the left and right of the gel.
Table 2 Detection of Pfs25 and Pvs25 in artificial mixed








Pfs25 Pvs25 Pfs25 Pvs25
Pfs25L (0.1) + Pvs25L (106) − + − +
Pfs25L (1) + Pvs25L (106) − + − +
Pfs25L (10) + Pvs25L (106) + + + +
Pfs25L (102) + Pvs25L (106) + + + +
Pfs25L (105) + Pvs25L (106) + + + +
Pfs25L (106) + Pvs25L (105) + + + +
Pfs25L (106) + Pvs25L (102) + + + +
Pfs25L (106) + Pvs25L (10) + + + +
Pfs25L (106) + Pvs25L (1) + − + −
Pfs25L (106) + Pvs25L (0.1) + − + −
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bers were assessed. Specificity of PCR assays was analysed
against genomic DNA (five isolates each) of Plasmodium
malariae, Plasmodium ovale and P. knowlesi. The nested
RT-PCR method targeting Pfs25 with primers Pfs25-1,
Pfs25-2, Pfs25-3 and Pfs25-4 developed by Babiker and
colleagues was also used for evaluation [20].
Data analysis
Diagnostic performance for multiplex-nested RT-PCR was
evaluated with the results from single-nested RT-PCR
assay of the same cDNA templates as the gold standard.
Performance indices were the number of true positive
(TP), number of true negative (TN), number of false posi-
tive (FP) and number of false negative (FN). Sensitivity
was expressed as TP/(TP+FN) and specificity as TN/
(TN+FP). The likelihood ratios for a positive test result
were calculated as sensitivity/(1 – specificity), and for a
negative test result as (1 – sensitivity)/specificity [21]. Dif-
ferences in parasite densities between gametocyte-
positives and gametocyte-negatives by microscopy were
calculated by using the Mann–Whitney U test. A 2-tailed
p value of <0.05 is considered significance.
Results
Detection limits of single-nested RT-PCR for Pfs25 and
Pvs25
Single-nested PCR targeting Pfs25 and Pvs25 could amp-
lify genomic DNA of P. falciparum and P. vivax generat-
ing products of expected sizes, i.e. 201 and 115 bp,
respectively (Figure 1). Likewise, concordant results were
obtained from cDNA templates generated from mRNA of
these parasite species. The minimum dilutions of either P.
falciparum or P. vivax genomic DNA that gave reprodu-
cible positive results were 10 copies. Neither PCR assays
exhibited cross-reactivity with genomic DNA from non-
matched malaria species, indicating specificity of these
tests. Meanwhile, a minimum of 100 copies was required
for successful amplification of Pfs25L by the RT-PCR
method developed by Babiker and colleagues [20].
Detection limits of multiplex-nested RT-PCR
The multiplex-nested RT-PCR developed herein gave
single 201-bp product for P. falciparum and 115-bp
product for P. vivax, identical to single-nested PCR tar-
geting each gene. Neither cross-hybridization nor false
amplification between primers for Pfs25 and Pvs25 was
observed when both malaria DNA were used as tem-
plates. The minimum detection limits were 10 copies of
template DNA and the results were reproducible in five
assays with different DNA templates. The sensitivity
remained unaltered when numerous amounts of DNA
templates from the other malaria species were added in
the reactions, e.g. 10 copies of P. vivax DNA mixed with1 x 106 copies of P. falciparum DNA (Table 2). Results
were essentially the same when cDNA of different iso-
lates was used as templates.Microscopy and 18S rRNA PCR diagnosis
Malaria was microscopically diagnosed in 157 of 235 fe-
brile patients. Most patients were infected with either P.
falciparum (n = 76) or P. vivax (n = 80). Co-infection
with both species was observed in a patient. Besides
asexual blood stages, P. falciparum gametocytes were
observed in eight isolates (8.9% of total P. falciparum-
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30 isolates (31.1% of total P. vivax-positives by 18S
rRNA PCR). Meanwhile, 18S rRNA PCR gave concord-
ant results with microscopy in 215 blood samples. Mi-
croscopy under-diagnosed 11 out of 12 patients who had
co-infections with ≥2 malaria species (Table 3). Further-
more, eight microscopy-negative samples were positive
for P. falciparum (n = 7) or P. vivax (n = 1).
Diagnostic performance of Pfs25 and Pvs25 mRNAs in
clinical samples
Single-nested RT-PCR targeting Pfs25 gave positive
results in 77 blood samples (89.5% of total P. falciparum
positives by 18S rRNA PCR) whereas 82 samples were
positive for Pvs25, indicating the presence of mature
gametocytes in these patients (91.1% of total P. vivax
positives by 18S rRNA PCR). No amplification occurred
when RNA of these isolates collected prior to cDNA
synthesis was added in the assays, indicating no genomic
DNA contamination. Results inferred from multiplex-Table 3 Microscopy and molecular diagnosis of malaria










Pfs25 Pvs25 Pfs25 Pvs25
Monoinfection
P. falciparum 76 75 − − − −
Gametocyte 8 − 68 − 67 −
P. vivax 80 78 − − − −




1 10 − − − −
Gametocyte 0 − 9 6 8 6
P. vivax and
P. malariae
0 1 − − − −
Gametocyte 0 − 0 1 0 1
P. falciparum,
P. vivax
0 1 − − − −
and P. malariae
Gametocyte 0 − 0 1 0 1
Total malaria
positive cases
157 165 − − − −
Total P. falciparum 77 86 − − − −
Gametocyte (%)* 8 (8.9) − 77 (89.5) − 75 (87.2) −
Total P. vivax 81 90 − − − −
Gametocyte (%)** 30 (31.1) − − 82 (91.1) − 82 (91.1)
* Percentage of P. falciparum gametocyte positives per total P. falciparum
positives by 18S rRNA PCR.
** Percentage of P. vivax gametocyte positives per total P. vivax positives by
18S rRNA PCR.
Dashes indicate no applicable data.nested RT-PCR revealed that P. falciparum and P. vivax
gametocytes co-existed in four of 11 patients who were
co-infected with both these malaria species (diagnosed
by 18S rRNA PCR). Likewise, similar results were
obtained when multiplex-nested RT-PCR was applied to
the same cDNA samples (87.2% and 91.1% for P. falcip-
arum and P. vivax, respectively) except that single-
nested RT-PCR targeting Pfs25 yielded two more posi-
tive results than multiplex-nested RT-PCR (Table 3).
With results from single RT-PCR as standard, multiplex-
nested RT-PCR provided high sensitivity and specificity
for amplification of Pfs25 and Pvs25. Furthermore, high
values of likelihood ratios of positive test result (82.4 for
Pvs25 to infinity for Pfs25) was noted whereas
multiplex-nested RT-PCR offered very low values of like-
lihood ratios of negative test results (Table 4). Both sin-
gle and multiplex-nested RT-PCR contributed greater
efficacy for diagnosing gametocytes of P. falciparum and
P. vivax than microscopy and the performance was more
pronounced for those of P. falciparum (Table 4).Transmission seasons and gametocyte prevalence
The prevalence of P. falciparum isolates containing
gametocytes collected in dry season was not significantly
different from that collected in wet season. Likewise, no
significant seasonal difference was observed between the
prevalence of isolates harbouring P. vivax gametocytes.
These findings remain the same regardless of the meth-
ods (microscopy, single-nested RT-PCR or multiplex-
nested RT-PCR) deployed for gametocyte detection
(Table 5). However, parasite density of P. vivax has sig-
nificant influence on gametocyte detection by micros-
copy whereas this effect was not evident for P.
falciparum (Table 6).Table 4 Diagnostic performance of multiplex nested RT-
PCR for Pfs25 and Pvs25 with single nested RT-PCR as
reference
Gametocytes (%)
P. falciparum P. vivax
Sensitivity 75/77 (97.4) 81/82 (98.9)
Specificity 80/80 (100) 80/81 (98.8)
Likelihood ratio of positive test * 82.4
Likelihood ratio of negative test 0.03 0.01








* Denominator is zero.
Table 5 Prevalence of P. falciparum and P. vivax
gametocytes among isolates collected in dry and wet
seasons
Diagnostic method Dry season Wet season p value
n % positive* n % positive*
Microscopy
P. falciparum gametocyte 3 6.4 3 7.7 0.81
P. vivax gametocyte 17 34 13 32.5 0.88
Single nested RT-PCR
P. falciparum gametocyte 40 85.1 35 89.7 0.52
P. vivax gametocyte 46 92 36 90 0.74
Multiplex nested RT-PCR
P. falciparum gametocyte 42 89.4 35 89.7 0.95
P. vivax gametocyte 46 92 36 90 0.74
18S rRNA PCR
P. falciparum 47 − 39 − −
P. vivax 50 − 40 − −
* total number of positives for a given species by 18S rRNA PCR.
- denotes not applicable.
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Recent molecular epidemiological surveys of malaria in
Thailand have revealed that all five Plasmodium species
circulate in this country. Most malaria cases are caused
by P. falciparum (~56.8% of all species) and P. vivax
(~41.3%). It is noteworthy that co-infections of both
these species contributed ~12.5% of all malaria cases;
the highest prevalence of ~23–24% occurred along theTable 6 Parasite densities of isolates with monoinfections
of P. falciparum and of P. vivax collected in dry and in
wet seasons
Category Parasite density (parasites/μL)
Dry season Wet season
P. falciparum*
with gametocyte n = 3 n = 5
range 1560–7000 930–36630
median 2960 6695




with gametocyte n = 17 n = 11
range 11640–70080 # 6090–49320 #
median 19360 9630
no gametocyte n = 29 n = 21
range 0–36360 304–16360
median 6560 2740
* Verification of monoinfection by 18S rRNA PCR.
# Parasite densities between isolates with and without detectable
gametocytes by microscopy were significantly different (p< 0.001, Mann–
Whitney U test).Thailand and Myanmar borders [18,19]. Therefore, mal-
aria control by transmission-reducing interventions,
such as gametocytocidal drugs or sexual stage vaccines,
requires simultaneous assessment of human infectious
reservoirs of both Plasmodium species. The multiplex-
nested RT-PCR developed herein offered high diagnostic
performance with sensitivity and specificity over 97%
when results from single-nested RT-PCR targeting each
of these transcripts were used as standard. Multiplex-
nested RT-PCR detected gametocytes of P. falciparum
and P. vivax 9.50 and 2.73 times more patient samples,
respectively, than was determined by microscopy. It is
noteworthy that 87.4% of P. falciparum and 91.1% of P.
vivax clinical isolates in Umpang District contained
gametocytes based on detection of Pfs25 and Pvs25
mRNA by multiplex-nested RT-PCR and total malaria
species identified by 18S rRNA PCR. Similarly, molecular
surveys in Kenya and Tanzania revealed 89.3–92.3% P.
falciparum gametocyte prevalence despite differences in
disease endemicity between these countries and Thai-
land [22]. The high prevalence of submicroscopic gam-
etocyte carriage has been hypothesized to ensure
gametocyte survival by avoiding substantial stimulation
for anti-gametocyte immune responses [23,24] and de-
velopmental success in vector by preventing damage of
mosquito midgut during ookinete invasion through oo-
cyst development [24-26].
A recent study using P. falciparum isolates from
patients in Tak Province who had febrile symptom
~3 days (range one to eight days) before blood sample
collection (n = 44) revealed that all isolates gave positive
results for RT-PCR targeting Pfg377, a female
gametocyte-specific mRNA, whereas microscopy
detected gametocytes in only six isolates. Subsequent
in vitro cultivation resulted in gametocyte production in
89% of isolates as detected by microscopy [27]. Mean-
while, all except one malaria patients in this study had
fever one day prior to blood sample collection. Although
it is likely that there could be some expression of Pvs25
and Pfs25 at the early stages of gametocyte maturation,
probably from leaky transcription or low-level transcrip-
tion, Pvs25 and Pfs25 mRNA in blood samples are
mainly from mature gametocytes. Taken together, it
seems that almost all patients infected with P. falcip-
arum in Tak province had mature gametocytaemia
within a few days after onset of febrile symptoms albeit
the majority existing below microscopic detection
threshold. Likewise, similar findings were demonstrated
in P. vivax-infected patients, suggesting that malaria
transmission could occur at the beginning or soon after
the febrile onset in this endemic area. By contrast, a sur-
vey of P. falciparum gametocytes among patients in an
endemic area in Tak Province by RT-PCR using the
method described by Babiker et al has shown only 15 of
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verse transcriptase-loop-mediated isothermal amplifica-
tion (RT-LAMP) provided slightly superior results
(29.2%) [28]. Discrepancy in prevalence of gametocyte
carriage may not be directly compared between studies
because of non-identical clinical samples and method-
ology. However, there remains a possibility that the de-
tection methods conferred different diagnostic
sensitivity. Importantly, the minimum diagnostic thresh-
old of the multiplex-nested RT-PCR in this study was 10
copies of templates. Although estimation of detection
limit of the multiplex-nested RT-PCR in this study did
not directly reflect the actual number of gametocytes in
the samples, it is likely that each mature gametocyte of
P. falciparum or P. vivax possesses several copies of
Pfs25 mRNA or Pvs25 mRNA; thereby a single gameto-
cyte is potentially sufficient to give a positive result.
It has been noted that P. falciparum gametocyte car-
riage is more common in areas with high malaria trans-
mission intensity and the younger age group seems to
have higher gametocyte prevalence than in an older age
group. However, age-dependent patterns of gametocyte
carriage for P. falciparum and P. vivax have not been
documented in this study, consistent with previous find-
ings that in areas with low transmission intensity, age
groups of infected individuals seem not to be apparently
associated with gametocyte prevalence [29-31]. Mean-
while, the prevalence of gametocyte carriage relative to
all malaria cases as detected by either microscopy or
multiplex-nested RT-PCR in this study seems to show
no significant seasonal fluctuation as previously noted
[32,33]. Discrepancy could arise from the small sample
size in this study, differences in intensity of malaria ex-
posure among subjects, competency of routine micro-
scopists in diagnosing gametocytes of P. vivax or other
unknown factors. Nevertheless, the high prevalence of
gametocyte carriage detected by multiplex-nested RT-
PCR for both P. falciparum and P. vivax in both high
(wet season) and low (dry season) transmission periods
could ensure sustainability of malaria endemicity in the
study population.
The prevalence of individuals with gametocytaemia
based on microscopy showed remarkable spatial vari-
ation. However, sensitivity of gametocyte detection by
microscopy per se could be influenced by the experience
of microscopists, the quality of slide preparation and the
number of microscopic fields examined [1-3]. Herein,
patients who carried microscopically patent P. vivax
gametocytaemia had significantly higher median parasite
density than those without detectable gametocytes by
microscopy. Therefore, a higher parasite density may
offer a better chance for detecting gametocytes of P.
vivax prior to anti-malarial treatment. Importantly, a
number of factors could influence microscopically patentgametocytaemia, e.g. exposure to anti-malarial drugs,
increased in body temperature or anaemia [1]. These
constraints, compromising effective assessment of gam-
etocyte carriage, could be alleviated by deployment of
RT-PCR-based methods for detecting gametocyte-
specific mRNA with remarkably higher sensitivity than
conventional microscopy. Because the patterns and dy-
namics of gametocyte carriage in malaria-infected indivi-
duals have important contributions to the capability of
malaria transmission and persistence in each endemic
area, simultaneous detection of both P. falciparum and
P. vivax gametocytaemia by multiplex-nested RT-PCR
developed herein will be useful in areas where both mal-
aria species co-circulate.
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